Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-01

Clinical Trial Update: Simultaneous RZV and aIIV4 Vaccination [Phase 4]

View source ↗

Summary

Phase 4 trial by Duke University evaluating simultaneous administration of the recombinant zoster vaccine with an adjuvanted quadrivalent influenza vaccine; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluad Quadrivalent (adjuvanted influenza vaccine quadrivalent)
  • Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: Duke University | Conditions: Pain, Quality of Life | Phase 4 | Status: COMPLETED | Results posted: 2024-05-01